Publishing research using ab18450? Please let us know so that we can cite the reference in this datasheet.
ab18450 has been referenced in 6 publications.
- Shi Q et al. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma. Cancer Lett 432:56-68 (2018). PubMed: 29890208
- Chang TZ et al. Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing. Biomater Sci 5:223-233 (2017). PubMed: 27918020
- Daschkey S et al. MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways. PLoS One 8:e56334 (2013). IP . PubMed: 23418555
- Doi T et al. IgA plasma cells express the negative regulatory co-stimulatory molecule programmed cell death 1 ligand and have a potential tolerogenic role in the intestine. Biochem Biophys Res Commun 425:918-23 (2012). Blocking . PubMed: 22906740
- Hausmann M et al. BCL-2 Modifying Factor (BMF) Is a Central Regulator of Anoikis in Human Intestinal Epithelial Cells. J Biol Chem 286:26533-40 (2011). PubMed: 21673109
- Coughlan L et al. In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery. J Virol 83:6416-28 (2009). Flow Cyt . PubMed: 19369326